Pediatrix Medical Group (NYSE:MD) Price Target Lowered to $16.00 at UBS Group

Pediatrix Medical Group (NYSE:MD - Get Free Report) had its price target cut by research analysts at UBS Group from $18.50 to $16.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a "neutral" rating on the stock. UBS Group's target price suggests a potential upside of 11.57% from the company's current price.

Other analysts have also issued research reports about the company. Macquarie upped their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday. StockNews.com raised shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Finally, Truist Financial cut their price target on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $16.67.

Pediatrix Medical Group Price Performance

Shares of NYSE MD traded down $0.19 during mid-day trading on Monday, hitting $14.34. 865,244 shares of the company's stock traded hands, compared to its average volume of 675,735. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. Pediatrix Medical Group has a 1 year low of $6.62 and a 1 year high of $17.67. The company's 50-day moving average is $13.70 and its two-hundred day moving average is $14.05. The company has a market capitalization of $1.23 billion, a P/E ratio of -11.95, a PEG ratio of 1.74 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.08. The firm had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company's revenue for the quarter was down 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.20 EPS. On average, equities analysts anticipate that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of institutional investors have recently bought and sold shares of the company. Nomura Asset Management Co. Ltd. raised its holdings in Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after buying an additional 1,220 shares during the period. GAMMA Investing LLC increased its holdings in shares of Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after acquiring an additional 1,765 shares during the period. Parkside Financial Bank & Trust increased its stake in shares of Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares in the last quarter. AlphaQuest LLC lifted its stake in Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after buying an additional 2,012 shares in the last quarter. Finally, Smartleaf Asset Management LLC grew its holdings in Pediatrix Medical Group by 750.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after buying an additional 6,090 shares during the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.